pharma · Metastatic Solid Tumor · Advanced or Metastatic Solid Tumors · HOWL
Werewolf Therapeutics
Werewolf Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Milton, GB HQ
2017 Founded
53 Employees
Public company Type
HOWL · NYSE Ticker
Company details
- Status
- Public
- HQ
- Milton, GB
- Founded
- 2017
- Employees
- 53
- Programs
- 2
- Drugs
- 0
- Patents
- 10
Werewolf Therapeutics projects
2 ClinicalTrials.gov programs sponsored by Werewolf Therapeutics.
Werewolf Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Werewolf Therapeutics have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.